The 100% rapid rescreening is efficient in the detection of false-negative results and varies according to the quality of the sample: a Brazilian experience

被引:5
作者
Claudio Manrique, Edna Joana [1 ]
do Nascimento Tavares, Suelene Brito
Alves Souza, Nadja Lindany
Pinheiro Albuquerque, Zair Benedita
Zeferino, Luiz Carlos [3 ]
Amaral, Rita Goreti [2 ]
机构
[1] Univ Fed Goias, Goiania, Go, Brazil
[2] Univ Fed Goias, Fac Farm, Goiania, Go, Brazil
[3] Univ Estadual Campinas, Fac Ciencias Med, Dept Tocoginecol, Campinas, SP, Brazil
来源
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA | 2007年 / 29卷 / 08期
关键词
Uterine cervical neoplasms/diagnosis; Cytodiagnosis; False negative reactions; Mass screening; Quality control; Quality assurance; health care/methods;
D O I
10.1590/S0100-72032007000800004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
PURPOSE: to evaluate the efficiency of the 100% rapid rescreening in the detection of false-negative results and to verify whether the results vary according to the adequacy of the sample and the woman's age group. METHODS: to evaluate the efficiency of the rapid rescreening, the 5,530 smears classified as negative by the routine screening, after being submitted to the rapid rescreening of 100%, were compared with the rescreening of the smears on the basis of clinical criteria and 10% random rescreening. For statistical analysis, the variables were evaluated descriptively and the Chi(2) test and the Cochran-Armitage test were applied to compare results. RESULTS: of the 141 smears identified as suspicious according to the rapid rescreening method, 84 (59.6%) cases were confirmed in the final diagnosis, of which 36 (25.5%) were classified as atypical squamous cells of undetermined significance, five (3.5%) as atypical squamous cells that cannot exclude high-grade squamous intraepithelial lesion, 34 (24.1%) as low-grade squamous intraepithelial lesion, six (4.3%) as high-grade squamous intraepithelial lesion, and three (2.1%) as atypical glandular cells. Of the 84 suspect smears confirmed in the final diagnosis, 62 (73.8%) smears were classified as adequate and 22 (26.2%) as adequate but with some limitation, but no significant difference was observed with the woman's age. CONCLUSIONS: the results of this study show that rapid rescreening is an efficient option for internal quality control for the detection of false-negative cervical smear results. In addition, it should be noted that rapid rescreening performed better when the sample was classified as adequate for analysis; however, it did not vary according to the woman's age group.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 25 条
[1]   Quality assurance in cervical smears - 100% rapid rescreening vs. 10% random rescreening [J].
Amaral, RG ;
Zeferino, LC ;
Hardy, E ;
Westin, MCD ;
Martinez, EZ ;
Montemor, EB .
ACTA CYTOLOGICA, 2005, 49 (03) :244-248
[2]  
Amaral Rita Goreti, 2003, J. Bras. Patol. Med. Lab., V39, P151, DOI 10.1590/S1676-24442003000200010
[3]  
Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P1
[4]  
[Anonymous], 2006, Rev. Bras. Ginecol. Obstet., V28, P486, DOI 10.1590/S0100-72032006000800008
[5]   Rapid (partial) prescreening of cervical smears: the quality control method of choice? [J].
Brooke, D ;
Dudding, N ;
Sutton, J .
CYTOPATHOLOGY, 2002, 13 (04) :191-199
[6]   Natural history of cervical intraepithelial neoplasia - A meta-analysis [J].
Cantor, SB ;
Atkinson, EN ;
Cardenas-Turanzas, M ;
Benedet, JL ;
Follen, M ;
MacAulay, C .
ACTA CYTOLOGICA, 2005, 49 (04) :405-415
[7]   Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review [J].
Davey, E ;
Barratt, A ;
Irwig, L ;
Chan, SF ;
Macaskill, P ;
Mannes, P ;
Saville, AM .
LANCET, 2006, 367 (9505) :122-132
[8]   Rapid rescreening of cervical smears for internal quality control [J].
Diehl, ARS ;
Prolla, JC .
ACTA CYTOLOGICA, 1998, 42 (04) :949-953
[9]   Rapid screening: a comparative study [J].
Dudding, N ;
Hewer, EM ;
Lancucki, L ;
Rice, S .
CYTOPATHOLOGY, 2001, 12 (04) :235-248
[10]  
Ferraz MDMD, 2005, ACTA CYTOL, V49, P639